BIS icon

ProShares UltraShort NASDAQ Biotechnology

17.13 USD
-0.08
0.46%
Updated Jan 23, 11:18 AM EST
1 day
-0.46%
5 days
-4.36%
1 month
-3.33%
3 months
10.23%
6 months
15.43%
Year to date
-4.89%
1 year
-2.50%
5 years
-68.49%
10 years
-89.35%
0
Funds holding %
of 6,823 funds
Analysts bullish %

Fund manager confidence

Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)

122% more capital invested

Capital invested by funds: $387K [Q2] → $858K (+$471K) [Q3]

100% more first-time investments, than exits

New positions opened: 2 | Existing positions closed: 1

100% more repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 1

17% more funds holding

Funds holding: 6 [Q2] → 7 (+1) [Q3]

11.19% more ownership

Funds ownership: 11.61% [Q2] → 22.81% (+11.19%) [Q3]

Research analyst outlook

We haven’t received any recent analyst ratings for BIS.

Financial journalist opinion

Charts implemented using Lightweight Charts™